Biomerica, Inc. (NASDAQ:BMRA) Short Interest Up 39.5% in December

Biomerica, Inc. (NASDAQ:BMRA) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 41,348 shares, a growth of 39.5% from the November 30th total of 29,633 shares. Approximately 1.7% of the company’s stock are short sold. Based on an average daily volume of 23,098 shares, the short-interest ratio is currently 1.8 days. Based on an average daily volume of 23,098 shares, the short-interest ratio is currently 1.8 days. Approximately 1.7% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Biomerica in a research report on Tuesday, October 14th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Biomerica Price Performance

BMRA opened at $2.66 on Tuesday. The company has a market capitalization of $7.85 million, a PE ratio of -2.77 and a beta of 0.06. Biomerica has a fifty-two week low of $2.11 and a fifty-two week high of $10.16. The business has a 50-day moving average of $2.52 and a 200-day moving average of $2.91.

Biomerica Company Profile

Biomerica, Inc is a developer, manufacturer and marketer of in vitro diagnostic tests for clinical diagnostic, life science research and food safety applications. The company’s product portfolio includes enzyme-linked immunosorbent assays (ELISAs), lateral flow immunoassays, point-of-care devices and specialty reagents designed to aid in the detection and monitoring of gastrointestinal, metabolic and autoimmune conditions. Biomerica’s diagnostics are used by hospitals, clinical and reference laboratories, and research institutions seeking solutions for early disease detection and patient management.

Key offerings from Biomerica include serological tests for celiac disease and gluten intolerance, quantitative assays for colorectal cancer screening markers such as M2-PK, and a range of point-of-care kits for metabolic monitoring.